Seattle Genetics Reports Second Quarter 2017 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/4/2026
- Equities close higher as softer jobs data quiets rate-hike expectations
- U.S. economy adds fewer jobs than expected as unemployment rate ticks higher
- Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
- Citi says rate volatility without Fed repricing is concerning
- U.S. credit-reporting stocks fall as FHFA weighs two-bureau mortgage rule
- Equities close higher as softer jobs data quiets rate-hike expectations
- Cantor Fitzgerald on Rivian (RIVN): 'pre-announced that it delivered 19,248 vehicles in 3Q26, above our estimate'
- DISH DBS emerges from bankruptcy, cuts debt by $4.35 billion
- Tanker struck by projectile in Strait of Hormuz
- AppLovin shares fall after court denies request against Unity
Seattle Genetics (SGEN) Tops Q2 EPS by 3c
July 27, 2017 4:43 PM EDTSeattle Genetics (NASDAQ: SGEN) reported Q2 EPS of ($0.39), $0.03 better than the analyst estimate of ($0.42). Revenue for the quarter came in at $108.2 million versus the consensus estimate of $108.8 million.
As of June 30, 2017, Seattle Genetics had $473.0 million in cash, cash equivalents and investments.
2017 Financial... More
